![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Antoniu Sabina A
Publisher: Informa Healthcare
ISSN: 1472-8222
Source: Expert Opinion on Therapeutic Targets, Vol.15, Iss.11, 2011-11, pp. : 1333-1335
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Tadalafil: In Pulmonary Arterial Hypertension
By Croxtall Jamie D. Lyseng-Williamson Katherine A.
Drugs, Vol. 70, Iss. 4, 2010-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Sitaxentan: In Pulmonary Arterial Hypertension
Drugs, Vol. 67, Iss. 5, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Dasatinib linked to pulmonary arterial hypertension
Reactions Weekly, Vol. 1, Iss. 1368, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)